{"schema_version":"secwatch.filing_event.v1","accession":"0001301787-22-000021","form_type":"8-K","ticker":"BXC","cik":"0001301787","company_name":"BlueLinx Holdings Inc.","filed_at":"2022-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.134298+00:00","generated_at":"2026-06-26T01:18:41.568977+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BlueLinx Q1 net sales $1.3B (+27%), diluted EPS $13.19 (+110%), record Adj. EBITDA $202M","bullets":["Net sales of $1.3B (+27% YoY); diluted EPS of $13.19 (+110% from $6.28).","Adjusted EBITDA $202M (+90%); gross margin expanded 470 bps to 22.3%.","Specialty product sales +36% to $768M; gross margin 24.0% (up 470 bps).","Board authorized $100M share repurchase; $60M accelerated share repurchase starting this week.","Net leverage 0.9x; available liquidity $421M; free cash flow near breakeven."],"urls":{"canonical":"https://secwatch.observer/filing/0001301787-22-000021","json":"https://secwatch.observer/filing/0001301787-22-000021.json","markdown":"https://secwatch.observer/filing/0001301787-22-000021.md","text":"https://secwatch.observer/filing/0001301787-22-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1301787/000130178722000021/0001301787-22-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1301787/000130178722000021/bxc-20220503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T01:18:41.568977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}